EGFR and head and neck cancer: Currently, the treatment for head and neck cancer mainly involves surgical eradication, radiotherapy (RT), chemotherapy (CT), and epidermal growth factor receptor (EGFR)-targeted drug cetuximab for both HPV(+) and HPV(−) subtypes (Moskovitz et al., 2018).